Due to the different degree of response to drug dosage and disease progression from ALS-associated mutants between human (A4V) and mouse (G93A), we validated mode of action of ebselen-based compounds in mouse model’s mutant by solving co-crystalised structures of G93A SOD1. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.